Email Updates

Search form

You are here

AVAC in the News

  • Truvada combina dos medicamentos antirretrovirales que pueden reducir el riesgo de contagio de la enfermedad en un 73%.

    May 11, 2012
    Peru21
  • Could we be one step closer to a world without HIV AIDS?Hopes are rising after a panel of US health experts has, for the first time, backed a drug to prevent HIV infection in healthy people.

    May 11, 2012
    ABC Radio Australia
  • The US Food and Drug Administration (FDA) took a decisive step yesterday towards approving the use of the combination pill Truvada (tenofovir/FTC) as a prevention method for HIV-negative people.

    May 11, 2012
    aidsmap
  • Truvada is safe and effective enough as a preventative medicine, Food and Drug Administration staff concluded in a report yesterday.

    May 9, 2012
    Bloomberg News
  • Recent studies have shown that antiretroviral drugs can be used not only to treat HIV, but also to prevent infection in the first place.

    April 25, 2012
    Voice of America
  • The story of pre-exposure prophylaxis for HIV -- using medications to prevent infection -- was anything but easy to understand at the CROI.

    March 12, 2012
    MedPage Today
  • The failure of a daily pill to protect healthy African women against AIDS may not have been the pill’s fault but the women’s reluctance to take it, scientists at an important AIDS conference in Seattle were told this week.

    March 12, 2012
    New York Times
  • Scientists are scrutinizing a new approach to preventing the spread of HIV that involves healthy people taking drugs to keep them from being infected by partners with the virus that causes AIDS.

    March 7, 2012
    Wall Street Journal
  • The day of the assembly-line circumcision is drawing closer.

    January 30, 2012
    New York Times
  • The journal Science has named an AIDS study as its 2011 Breakthrough of the Year. The clinical trial found that antiretroviral drugs can be used to dramatically lower the risk of transmitting HIV. The clinical trial is known as HPTN 052. It proved that giving the drugs to HIV infected people sooner made them 96 percent less likely to transmit the virus to their uninfected partners.

    December 28, 2011
    Voice of America

Pages